Unrestricted Educational Research Grant
07/01/2005 - 12/31/2007 (PI)Schering AG (Germany)
Study to Characterize the Effects of Testosterone on the Cavernosal Nerve Structure Using Light and Electron Microscopy
07/20/2006 - 07/19/2007 (PI)Auxilium Pharmaceuticals, Inc.
In Vivo Assessment of EP2/EP4 Agonists (Serono) in Facilitating Male and Female Sexual Function
12/23/2002 - 06/30/2006 (PI)Serono Inc
Female Sexual Arousal: Clitoral and Vaginal Physiology
09/15/2000 - 06/30/2005 (PI)NIH/National Diabetes & Digestive & Kidney Diseases
5 R01 DK56846 04
Modulation of Erectile Physiology by Androgens & Phosphodiesterase Type 5 Inhibitor, Sildernafil
12/15/2002 - 06/30/2004 (PI)Pfizer, Inc.
The Effects of Intravaginal Administration of Rec 15/2615 Formulation on Genital Blood Flow
09/01/2002 - 08/31/2003 (PI)Recordati Industria Chimica E Farmaceutica S.p.A. (Italy)
In Vivo Modulation of Vaginal Smooth Muscle Tone and Genital Blood Flow by the Alpha I Antagonist (SH-19991012)
07/01/2001 - 06/30/2002 (PI)Molecular Design International, Inc
Effects of Estrogen and Androgen Deprivation and Replacement Therapy on Sildenafil Augmentation of Pelvic Nerve-Medicated Female Genital
12/15/2000 - 12/14/2001 (PI)Pfizer, Inc.
Potential Role of a Novel Nuclear Matrix Protein (nmt55) as a Tumor Marker in Human Breast Cancer Invasion and Metastases
07/01/1998 - 06/30/2001 (Dept Sponsor)Department of Defense/Army
Effects of P2 & 2 Agonist INS365 and INS45973 on Vaginal Mucosal Health in Oophoectomized Rabbits
09/08/2000 - 06/08/2001 (PI)Inspire Pharmaceuticals Inc
Showing 10 of 12 results.
Show All Results